
Metabolic Research
JSP-2-TRZ
$25.00 – $85.00 · 7 sizes
Dual GIP/GLP-1 receptor agonist research compound for studies of incretin signaling and energy homeostasis.
- Purity
- >99%
- Testing
- 3rd-party
- Shipping
- Tracked, discreet
$25.00In stock
1
For laboratory research use only. Not for human consumption. Full disclaimer
6 lab reports (COA) available for this product.
About JSP-2-TRZ
Dual incretin receptor engagement. A landmark compound in metabolic peptide science.
JSP-2-TRZ is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its novel twincretin mechanism has made it one of the most studied compounds in modern metabolic research, with particular interest in its effects on insulin secretion, glucagon suppression, gastric motility, and adipose tissue dynamics.
Research applications
- Dual GLP-1 and GIP receptor agonism mechanisms
- Insulin secretion and glucagon suppression pathways
- Gastric motility and appetite regulation research
- Adipose tissue metabolism and energy balance
- Lipid profile and cardiovascular metabolic marker studies
Lab reports (COA)
Independent third-party test results for JSP-2-TRZ, newest first.
| Batch | Size | Tested | Lab | Purity | Report |
|---|---|---|---|---|---|
| 030040BT | 40mg | Sep 11, 2026 | Freedom Diagnostics (HGTC group test) | 99.82% | View COA |
| Red Cap | 30mg | Aug 8, 2026 | Freedom Diagnostics (HGTC group test) | 99.91% | View COA |
| SPRI-XJT203-52226 | 20mg | Jun 13, 2026 | Freedom Diagnostics (supplier lot test) | 99.84% | View COA |
| SPRI-XJT40-52626 | 40mg | — | Freedom Diagnostics (supplier lot test) | 99.72% | View COA |
| SPRI-XJT202-52226 | 20mg | — | Freedom Diagnostics (supplier lot test) | 99.89% | View COA |
| SPRI-XJT20-52226 | 20mg | — | Freedom Diagnostics (supplier lot test) | 99.93% | View COA |



